Synapse - Find an Expert

66746 Results

Infarction with associated pseudosarcomatous changes mimics anaplasia in otherwise grade I meningiomas

Journal Article

Bale, T. A.; Benhamida, J.; Roychoudury, S.; Villafania, L.; Wrzolek, M. A.; Bouffard, J. P.; Bapat, K.; Ladanyi, M.; Rosenblum, M. K.
Modern Pathology (2020)

Fulltext@MSK | Save

A super-resolution framework for the reconstruction of T2-weighted (T2w) time-resolved (TR) 4DMRI using T1w TR-4DMRI as the guidance

Journal Article

Nie, X.; Saleh, Z.; Kadbi, M.; Zakian, K.; Deasy, J.; Rimner, A.; Li, G.
Medical Physics (2020)

Fulltext@MSK | Save

Strategies for effective physics plan and chart review in radiation therapy: Report of AAPM Task Group 275

Journal Article

Ford, E.; Conroy, L.; Dong, L.; de Los Santos, L. F.; Greener, A.; Gwe-Ya Kim, G.; Johnson, J.; Johnson, P.; Mechalakos, J. G.; Napolitano, B.; more...
Medical Physics (2020)

Fulltext@MSK | Save

Automated proton treatment planning with robust optimization using constrained hierarchical optimization

Journal Article

Taasti, V. T.; Hong, L.; Deasy, J. O.; Zarepisheh, M.
Medical Physics (2020)

Fulltext@MSK | Save

Technical Note: Integrating an open source Monte Carlo code “MCsquare” for clinical use in intensity-modulated proton therapy

Journal Article

Deng, W.; Younkin, J. E.; Souris, K.; Huang, S.; Augustine, K.; Fatyga, M.; Ding, X.; Cohilis, M.; Bues, M.; Shan, J.; more...
Medical Physics (2020)

Fulltext@MSK | Save

Daratumumab monotherapy for patients with intermediate-risk or high-risk smoldering multiple myeloma: A randomized, open-label, multicenter, phase 2 study (CENTAURUS)

Journal Article

Landgren, C. O.; Chari, A.; Cohen, Y. C.; Spencer, A.; Voorhees, P.; Estell, J. A.; Sandhu, I.; Jenner, M. W.; Williams, C.; Cavo, M.; more...
Leukemia (2020)

Fulltext@MSK | Save

Myelin water fraction estimation using small-tip fast recovery MRI

Journal Article

Whitaker, S. T.; Nataraj, G.; Nielsen, J. F.; Fessler, J. A.
Magnetic Resonance in Medicine (2020)

Fulltext@MSK | Save

Ivosidenib in IDH1-mutant, chemotherapy-refractory cholangiocarcinoma (ClarIDHy): A multicentre, randomised, double-blind, placebo-controlled, phase 3 study

Journal Article

Abou-Alfa, G. K.; Macarulla, T.; Javle, M. M.; Kelley, R. K.; Lubner, S. J.; Adeva, J.; Cleary, J. M.; Catenacci, D. V.; Borad, M. J.; Bridgewater, J.; more...
Lancet Oncology (2020)

Fulltext@MSK | Save

Primary chemoablation of low-grade upper tract urothelial carcinoma using UGN-101, a mitomycin-containing reverse thermal gel (OLYMPUS): An open-label, single-arm, phase 3 trial